BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells. - Wikidata - wikimedia - TriplyDB

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

http://www.wikidata.org/entity/Q40658343

about

Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation Cellular and molecular mechanisms of fibrosis Interaction of TGFβ and BMP signaling pathways during chondrogenesis Role of bone morphogenetic protein-7 in renal fibrosis Role of the TGF-β/BMP-7/Smad pathways in renal diseases Freeze-dried allograft-mediated gene or protein delivery of growth and differentiation factor 5 reduces reconstructed murine flexor tendon adhesions.In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7.Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.Analysis of gene expression in PTHrP-/- mammary buds supports a role for BMP signaling and MMP2 in the initiation of ductal morphogenesis.Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.Renal fibrosis.Gene expression analysis of the pleiotropic effects of TGF-β1 in an in vitro model of flexor tendon healing Smad mediated regulation of inhibitor of DNA binding 2 and its role in phenotypic maintenance of human renal proximal tubule epithelial cells.Gremlin induces cell proliferation and extra cellular matrix accumulation in mouse mesangial cells exposed to high glucose via the ERK1/2 pathway Y-box protein-1 is a transcriptional regulator of BMP7.TGF-β1 Suppresses Plasmin and MMP Activity in Flexor Tendon Cells via PAI-1: Implications for Scarless Flexor Tendon Repair.Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: implications for capillary basement membrane pathology.Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors.Role of Bone Morphogenetic Proteins-7 (BMP-7) in the Renal Improvement Effect of DangGui (Angelica sinensis) in Type-1 Diabetic Rats Fibrotic disease and the T(H)1/T(H)2 paradigm.Paracrine TGF-β signaling counterbalances BMP-mediated repression in hair follicle stem cell activation.Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.Clinicopathological significance of BMP7 expression in esophageal squamous cell carcinoma Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia.Musculin/MyoR is expressed in kidney side population cells and can regulate their function.MiR542-3p Regulates the Epithelial-Mesenchymal Transition by Directly Targeting BMP7 in NRK52e.Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.The anti-fibrotic effect of bone morphogenic protein-7(BMP-7) on liver fibrosis Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.Inhibitory effect of bone morphogenetic protein-7 on hepatic fibrosis in rats.Cellular and molecular factors in flexor tendon repair and adhesions: a histological and gene expression analysis.TGF-beta signal transduction in chronic kidney disease TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.The role of TGF-β in the pathogenesis of primary open-angle glaucoma.Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis.Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.Impact of Smad3 loss of function on scarring and adhesion formation during tendon healing.Alcohol Activates TGF-Beta but Inhibits BMP Receptor-Mediated Smad Signaling and Smad4 Binding to Hepcidin Promoter in the Liver.Human bone morphogenetic protein-7 does not counteract aristolochic acid-induced renal toxicity.Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy.

P2860

Q24294309-6060A309-7756-40EA-9837-884AE04BDAEA Q24648892-DF611971-5236-4EA7-A928-0211078B5EA5 Q27437636-3F0CA346-6111-4BE4-8BB0-3407768265D8 Q28080865-4B82D5E6-E505-4DE5-A5FF-3DF6AB55974B Q28278757-21A13720-A5FA-4AA0-9535-B73A2F34A48A Q33582282-3B8FAD56-149E-4EC8-97EF-1554DA517F76 Q33641428-C3ADCFA7-6766-403A-9E2C-C2750A273C10 Q33685580-FEF63AA2-DFAC-43FE-A1B1-50BCEDBA74B9 Q33822636-B71A85CE-2C37-4D68-988D-651309448233 Q34025148-607108FB-A9DD-4DBE-A86D-A2BA7B474E42 Q34417331-7EC81F48-0E0C-4A88-BCCB-091A494A8845 Q34516594-52E1DAE1-7521-4868-BB8E-55167A348356 Q34548148-3740EFF9-2655-485F-870C-CAC197F7E417 Q34581271-C424F8BD-E1BF-4A94-B1BB-1C2AA380E4B0 Q34669328-97BFAF09-5709-4933-85F1-F20B16DED37D Q34772461-E9BB95C7-48E8-4A28-8AE8-67A2F11857EF Q35087786-1F83341B-9D70-4743-9E7C-D7B0AE59972F Q35138504-5625C082-75AE-41DC-B7B8-52BEB7699FC6 Q35184637-9BC4F883-4ECF-4B4E-B5CB-F45758206C96 Q35852270-386C1DA6-E17E-47F2-95C6-C1917B23427B Q35949655-770C302F-2077-4C0E-87FC-6BD765878B2D Q35970142-4EEF0E8F-F796-4498-9828-F4ADD665F4AA Q35973726-0C1BF8C6-69B3-4E79-94E4-C2CED4740E20 Q36249725-B5C0C989-BA0D-42B2-816B-AFE15F5AFE93 Q36321197-701083AE-74C3-4576-BF98-0D387EB342FD Q36324840-2B6270EA-1453-4335-B5EA-32ABE4774AAC Q36371664-5B5D2106-1EA3-440B-B037-26BBBF684F90 Q36663411-BAB5FDC4-2B0D-436E-B1A4-1B28AC554188 Q36736835-021F57A6-E7D5-4782-A7E1-26F402194ECC Q36800325-E8104E6A-8C9E-4953-87AA-AD8418AB5A20 Q36971388-FE2A0DFA-C7A9-4F10-8F6B-642F00F5E2B4 Q37410310-23E9FBAD-65DF-4C9E-BD1F-F54817710C7A Q37884486-8B6F1EB3-9E9D-49F2-B70D-C3CA568EACC3 Q37958629-A95DA557-7BF3-408B-B8DC-BA33813CBD38 Q38046124-71544089-85A7-4BE6-BB85-3AA51FEEBB3B Q38083596-78E17D7B-08F3-4FD2-974F-73D81FE0BFAA Q38681589-89DAFBD5-CE42-4662-B999-04CBF6BDA55E Q38833757-B42FBDF2-2BAF-40BF-BA62-C3FFB92BEF5F Q38911611-7A815A9A-ED9E-4829-9D10-1139B9441E1E Q38930049-37C6E716-5757-4C18-9975-917348AB7DA1

P2860

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

http://www.wikidata.org/entity/Q40658343

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

@en

type

label

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

@en

prefLabel

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

@en

P1433

Q40658343-1C59A5F5-928A-44B2-8088-118FC0A4612F

P1476

Q40658343-51964918-F0AE-43DD-9D10-3AA2A1134589

P2093

Q40658343-490AC490-92CE-440E-8AEF-4D53E651D660

Q40658343-7C420BDA-95CA-4EB7-83B2-6512EC487DC0

P2860

Q40658343-1A91A3F0-F48B-4645-BB0F-3DBE591C22C1

Q40658343-339E9BF1-04BC-40ED-972A-ED9118DFA84D

Q40658343-50085E7F-F78C-4FEF-B3F5-FC0D6140482A

Q40658343-5A317ED6-07AB-4C1D-94E1-3077751D5A23

Q40658343-6409C995-322B-4221-B857-3A38964C2565

Q40658343-6D30FE56-21AE-4F2B-ADBD-6060417288C0

Q40658343-7B977F5D-1597-4A58-ADC7-4DC445BBBD44

Q40658343-83B6CAB0-DF50-48F6-AFC1-F769BA295793

Q40658343-84E5078E-1DAA-49F7-AFDC-F5D641D0950B

Q40658343-8FEEB1B1-A47C-4560-BDBD-6D9AF7D76A5A

P304

Q40658343-EC461B72-C9AD-48B4-B7FA-22AA2B733ED3

P31

Q40658343-F60BDF14-786E-4EAE-BF7D-3FAE95AA800A

P356

Q40658343-567EBDA6-01C9-472D-A87F-E32C6C4AD60F

P433

Q40658343-6625DD95-6162-47D5-84D8-4E8863DD440C

P478

Q40658343-5922EB32-D37D-4E84-A370-FE53AC43DF1D

P577

Q40658343-ADF88A2F-AFD7-420E-9690-AE896F56AECC

P5875

Q40658343-0ED8AC51-996C-4D64-99CF-23B2886FA529

P698

Q40658343-7C590958-394F-4299-B3CA-0942579EBA85

P356

AJPRENAL.00382.2002

P1433

American Journal of Physiology - Renal Physiology

P1476

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

@en

P2093

Raimund Hirschberg

http://www.w3.org/2001/XMLSchema#string

Shinong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The second type II module from human matrix metalloproteinase 2: structure, function and dynamics

Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function

Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells

A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye

Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys

Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease.

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.

Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells.

Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter.

P304

F1006-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00382.2002

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10820637

http://www.w3.org/2001/XMLSchema#string

P698

12676736

http://www.w3.org/2001/XMLSchema#string